Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 2 | 1194 | 791 | 0.0925 | 0.0829 | 0.6625 | 0.6809 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 1 | 1214 | 870 | 0.0789 | 0.0829 | 0.7166 | 0.6809 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1140 | 648 | 0.0833 | 0.0840 | 0.5684 | 0.5773 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1129 | 649 | 0.0813 | 0.0840 | 0.5748 | 0.5773 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1252 | 737 | 0.0872 | 0.0840 | 0.5887 | 0.5773 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2098 | 334 | 0.0923 | 0.0842 | 0.1592 | 0.1524 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1856 | 299 | 0.0815 | 0.0842 | 0.1611 | 0.1524 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1744 | 239 | 0.0788 | 0.0842 | 0.1370 | 0.1524 |
A-375 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1515 | 200 | 0.0715 | 0.0854 | 0.1320 | 0.1306 |
A-375 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1845 | 254 | 0.0865 | 0.0854 | 0.1377 | 0.1306 |
A-375 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 1 | 2057 | 251 | 0.0982 | 0.0854 | 0.1220 | 0.1306 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1822 | 269 | 0.0744 | 0.0857 | 0.1476 | 0.1490 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 2192 | 327 | 0.0894 | 0.0857 | 0.1492 | 0.1490 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 2292 | 344 | 0.0934 | 0.0857 | 0.1501 | 0.1490 |
A-375 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 3 | 1534 | 520 | 0.0744 | 0.0866 | 0.3390 | 0.3091 |
A-375 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 2 | 1594 | 450 | 0.0839 | 0.0866 | 0.2823 | 0.3091 |
A-375 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 1 | 1996 | 611 | 0.1016 | 0.0866 | 0.3061 | 0.3091 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1163 | 835 | 0.0758 | 0.0871 | 0.7180 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1381 | 996 | 0.0890 | 0.0871 | 0.7212 | 0.7176 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1460 | 1042 | 0.0966 | 0.0871 | 0.7137 | 0.7176 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1858 | 649 | 0.0874 | 0.0884 | 0.3493 | 0.3475 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1653 | 605 | 0.0758 | 0.0884 | 0.3660 | 0.3475 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 2097 | 686 | 0.1020 | 0.0884 | 0.3271 | 0.3475 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2198 | 268 | 0.0925 | 0.0889 | 0.1219 | 0.1262 |